Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy: PIK3CA activating mutations in invasive lobular breast carcinoma. Radiology and Oncology, v. 57, n. 2, p. 220–228, 22 Jun.2023.